Active Ingredient(s): Polythiazide + Prazosin
FDA Approved: * June 13, 1980
Pharm Company: * PFIZER
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Minizide Overview

Prazosin is a sympatholytic medication that is used to treat high blood pressure, anxiety, and posttraumatic stress disorder (PTSD).[2][3] Prazosin is an α1-blocker that acts as an inverse agonist at alpha-1 adrenergic receptors.[4] These receptors are found on vascular smooth muscle, where they are responsible for the vasoconstrictive action of norepinephrine.[3] They are also found throughout the central nervous system.&am...

Read more Minizide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Minizide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Polythiazide + Prazosin
  • Capsule: 0.5mg + 1mg, 0.5mg + 2mg, 0.5mg + 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Minizide: (3 results)

Sorted by National Drug Code
  • 0069-4300 Minizide 1 Oral Capsule by Pfizer Labs
  • 0069-4320 Minizide 2 Oral Capsule by Pfizer Labs
  • 0069-4360 Minizide 5 Oral Capsule by Pfizer Labs

Drugs with one or more similar ingredients: (5 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 February 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA